Clinical Trials Browser

Uveal Melanoma × Monophenol Monooxygenase × Clear all

NCT00084656 2022-04-14

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Phase 2 Completed

77 enrolled 13 charts

Uveal Melanoma, Melanoma